TipRanks
MRT Inc. (JP:6034)
:6034
Japanese Market
Want to see JP:6034 full AI Analyst Report?

MRT Inc. (6034) AI Stock Analysis

1 Followers

Top Page

JP:6034

MRT Inc.

(6034)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - Gpt-5.6Sol)
Rating:61Neutral
Price Target:
¥605.00
▼(-3.97% Downside)
Action:Reiterated
Date:08/18/26
The score is primarily supported by a strong, low-leverage balance sheet and improving profitability versus 2024, plus constructive technical momentum (price above key DMAs and positive MACD). Offsetting this are a high valuation (P/E 42.62) and weaker recent fundamentals momentum, including slightly declining TTM revenue and materially lower TTM free cash flow.
Positive Factors
Low Leverage
Very low leverage gives MRT a meaningful financial cushion and reduces exposure to interest costs or refinancing pressure. A stable equity base also preserves flexibility to maintain operations and pursue investment through weaker revenue or cash-generation periods.
Negative Factors
Revenue Contraction
Declining TTM revenue indicates that current business activity is not expanding and may limit operating leverage. Without renewed top-line growth, MRT has less opportunity to spread costs, rebuild stronger earnings, or improve returns on its stable capital base.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Very low leverage gives MRT a meaningful financial cushion and reduces exposure to interest costs or refinancing pressure. A stable equity base also preserves flexibility to maintain operations and pursue investment through weaker revenue or cash-generation periods.
Read all positive factors

MRT Inc. (6034) vs. iShares MSCI Japan ETF (EWJ)

MRT Inc. Business Overview & Revenue Model

Company Description
MRT Inc. operates a medical information platform. It provides Gaikin, a recruitment service specializing in part-time physicians; career, a job change support service for doctors; re:ray, a one stop outsourcing service; Door., an app to connect ne...

MRT Inc. Financial Statement Overview

Summary
Financials are mixed: the balance sheet is strong and conservatively levered (debt-to-equity ~0.09), but operating results remain modest with TTM revenue slightly down (~-2.7%) and profitability still thin (TTM net margin ~2.0%, operating margin ~3.2%). Cash flow is positive and reasonably aligned with earnings (FCF ~0.93x net income), yet TTM free cash flow has declined materially (~-27%), limiting the score.
Income Statement
56
Neutral
Balance Sheet
78
Positive
Cash Flow
61
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.99B4.19B4.17B5.41B8.74B4.47B
Gross Profit2.49B2.60B2.48B3.27B5.41B3.37B
EBITDA367.54M331.35M165.42M1.20B3.16B1.61B
Net Income81.33M55.77M-309.16M518.36M2.16B774.49M
Balance Sheet
Total Assets6.37B6.48B6.75B6.47B8.16B4.98B
Cash, Cash Equivalents and Short-Term Investments1.53B1.67B2.61B3.78B4.89B1.01B
Total Debt439.08M552.97M1.05B641.79M875.86M1.04B
Total Liabilities1.62B1.83B2.12B1.76B3.67B2.69B
Stockholders Equity4.75B4.65B4.52B4.58B4.39B2.22B
Cash Flow
Free Cash Flow271.99M409.83M461.79M-208.76M4.50B-308.61M
Operating Cash Flow293.17M417.84M503.04M-193.58M4.51B-298.89M
Investing Cash Flow-515.40M-623.37M-1.84B-243.61M-431.11M-206.51M
Financing Cash Flow-438.56M-730.16M161.77M-669.19M-203.98M-67.49M

MRT Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price630.00
Price Trends
50DMA
622.10
Negative
100DMA
623.84
Negative
200DMA
630.42
Negative
Market Momentum
MACD
-7.57
Negative
RSI
37.35
Neutral
STOCH
53.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6034, the sentiment is Negative. The current price of 630 is above the 20-day moving average (MA) of 602.70, above the 50-day MA of 622.10, and below the 200-day MA of 630.42, indicating a bearish trend. The MACD of -7.57 indicates Negative momentum. The RSI at 37.35 is Neutral, neither overbought nor oversold. The STOCH value of 53.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6034.

MRT Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
¥3.34B37.92―0.87%-6.56%―
58
Neutral
¥8.62B35.59―1.24%27.65%-28.38%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
49
Neutral
¥9.06B34.19―0.39%4.97%―
48
Neutral
¥2.64B-4.63――14.84%30.67%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6034
MRT Inc.
573.00
-125.00
-17.91%
JP:3628
Data Horizon Co., Ltd.
722.00
114.00
18.75%
JP:4438
Welby Inc.
289.00
-16.00
-5.25%
JP:9218
Mental Health Technologies Co. Ltd.
805.00
-9.58
-1.18%
JP:366A
Wellness Communications Corporation
1,160.00
-290.39
-20.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 18, 2026